CQC annual report: safer management of controlled drugs
14th August 2015
The UK Care Quality Commission (CQC) has published their 2014 annual report on the safer management of controlled drugs and made the following recommendations.
Recommendation for CQC
CQC should make information available to small organisations to advise them of the exemption provision in the regulations for the need to appoint a controlled drug accountable officer.
Recommendations for NHS England lead controlled drug accountable officers
NHS England lead controlled drug accountable officers should:
• use the changes to the regional structure from April 2015 as an opportunity to work more collaboratively so that there is greater national consistency of approach to delivering their controlled drug responsibilities
• engage with and formalise the support of clinical commissioning groups (CCGs) so that monitoring controlled drug prescription activity is a higher priority
• determine how best to engage with social care organisations in their area and should encourage local authorities to be engaged in controlled drug local intelligence networks (CD LINs).
Recommendations for NHS England
NHS England should provide guidance for occurrence reporting so that organisations understand what they need to report to the CD LIN.
Recommendation for all controlled drug accountable officers
Controlled drug accountable officers should share organisational learning from controlled drug-related incidents with their CD LINs and, where possible, develop links with their Medication Safety Officers to maximise these opportunities for learning.
- Pregabalin 75mg capsules: MHRA batch alert
- CQC annual report: safer management of controlled drugs
- Care of the dying: NICE guideline consultation
- Legislation changes for the availability of parenteral naloxone
- MHRA further measures to minimise risk of ONJ with denosumab and IV bisphosphonates
- Cochrane review: Antidepressants for the treatment of depression in people with cancer
- Ketamine 50mg/mL injection back in stock
- Phenobarbital 200mg/mL injection shortage
- Co-danthramer and strong co-danthramer capsules discontinued
- Ketamine supply update